Field Cancerization Therapies- Medical Dermatology and Beyond

The session focused on photodynamic therapy and field cancerization, presenting insights from Dr. Samis, a noted expert. The concept of field cancerization, which describes pre-cancerous changes in skin surrounding visible tumors, is significant for identifying high-risk areas for skin malignancies such as squamous cell carcinoma (SCC). Chronic ultraviolet (UV) exposure plays a crucial role in this process, leading to mutations and increased cancer risk, particularly in immunocompromised patients. Early interventions using therapies like topical agents (5-FU, imiquimod) and photodynamic therapy (PDT) are advocated to prevent the progression to invasive cancer. Field cancerization treatments are essential for managing extensive actinic keratoses and preventing SCC, enhancing patient compliance and tolerability through strategies like sun protection, tailored dosages, and combination therapies. Dr. Samis emphasized the importance of establishing a strong patient-physician relationship and customizing treatment plans based on individual risk profiles, especially in immunosuppressed patients. The session highlighted that effective treatment involves a multi-faceted approach, combining photodynamic therapy with topical agents and possibly surgical interventions for optimal outcomes. Overall, maintaining awareness of field cancerization's implications, incorporating prevention strategies, and customizing treatment protocols are vital for improving patient quality of life and reducing skin cancer incidence.